Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression

C Mao, S Yeh, J Fu, M Porosnicu, A Thomas… - Science translational …, 2022 - science.org
Tumor evasion of immune destruction is associated with the production of
immunosuppressive adenosine in the tumor microenvironment (TME). Anticancer therapies …
被引用次数：37 相关文章

Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression.

C Mao, S Yeh, J Fu, M Porosnicu… - Science …, 2022 - search.ebscohost.com
Tumor evasion of immune destruction is associated with the production of
immunosuppressive adenosine in the tumor microenvironment (TME). Anticancer therapies …
[PDF] duke.edu

[PDF][PDF] Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression

C Mao, S Yeh, J Fu, M Porosnicu, A Thomas… - dukespace.lib.duke.edu
Tumor evasion of immune destruction is associated with the production of
immunosuppressive adenosine in the tumor microenvironment (TME). Anticancer therapies …
[HTML] nih.gov

[HTML][HTML] Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression

C Mao, S Yeh, J Fu, M Porosnicu… - Science translational …, 2022 - ncbi.nlm.nih.gov
Tumor evasion of immune destruction is associated with the production of
immunosuppressive adenosine in the tumor microenvironment (TME). Anticancer therapies …

Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression.

C Mao, S Yeh, J Fu, M Porosnicu… - Science Translational …, 2022 - europepmc.org
Tumor evasion of immune destruction is associated with the production of
immunosuppressive adenosine in the tumor microenvironment (TME). Anticancer therapies …

Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression

C Mao, S Yeh, J Fu, M Porosnicu… - Science …, 2022 - pubmed.ncbi.nlm.nih.gov
Tumor evasion of immune destruction is associated with the production of
immunosuppressive adenosine in the tumor microenvironment (TME). Anticancer therapies …

Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression.

C Mao, S Yeh, J Fu, M Porosnicu, A Thomas… - 2022 - dukespace.lib.duke.edu
Tumor evasion of immune destruction is associated with the production of
immunosuppressive adenosine in the tumor microenvironment (TME). Anticancer therapies …